Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 ng » 10 mg (Expand Search), 10 nm (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 ng » 10 mg (Expand Search), 10 nm (Expand Search)
-
1041
-
1042
Decrease in optical density of <i>gerP</i> mutants in L-alanine and inosine.
Published 2013“…a<p>Spores were incubated in 0.5 mM L-alanine and 1 mM inosine. ∼65% decrease in OD<sub>600</sub> represents ∼100% germination. …”
-
1043
-
1044
-
1045
-
1046
-
1047
Demonstration of test steps.
Published 2025“…In sand column tests, specimens treated with cementing solution with ferric ion achieved the UCS of 2.83 MPa after five injection cycles, representing a 15-fold increase compared to conventional MICP-treated specimens under the same test conditions. …”
-
1048
-
1049
-
1050
-
1051
-
1052
-
1053
-
1054
-
1055
TNFα significantly decreases PRLR immunoreactivity in the outer root sheath of hair follicles.
Published 2013“…<p>(A) PRLR IR in the outer root sheath of control hair follicles (black arrows) was reduced in comparison PRLR IR after treatment with TNFα at concentrations of (B) 0.5 ng/ml and (C) 5 ng/ml. …”
-
1056
-
1057
-
1058
-
1059
-
1060
Treatment with rSFRP4 results in decreased Wnt signalling.
Published 2013“…Results represent the average of 3 experiments and bars represent the standard deviation (s.d) of the mean. *<i>P</i><0.05. (<b>B</b>) Representative immunoblots showing increased SFRP4 and decreased nuclear β-catenin protein expression in OVCAR3 cells following 72 hours treatment with rSFRP4 (5 µg/ml). …”